Provided by Tiger Trade Technology Pte. Ltd.

MESOBLAST LTD

2.460
+0.0502.07%
Volume:4.70M
Turnover:11.49M
Market Cap:3.19B
PE:-39.66
High:2.540
Open:2.460
Low:2.360
Close:2.410
52wk High:3.310
52wk Low:1.880
Shares:1.30B
Float Shares:786.49M
Volume Ratio:1.97
T/O Rate:0.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.062
EPS(LYR):-0.062
ROE:-9.86%
ROA:-4.11%
PB:4.02
PE(LYR):-39.66

Loading ...

Mesoblast to Host Webcast on Full-Year Financial Results and Corporate Update

Reuters
·
Aug 24

ASX Value Picks ALS And Two More Stocks Estimated Below Intrinsic Value

Simply Wall St.
·
Aug 24

3 Australian Penny Stocks With Strong Balance Sheets Worth Watching

Simply Wall St.
·
Aug 24

Mesoblast Stock Leads 3 Fast Growing ASX Picks With Strong Insider Ownership

Simply Wall St.
·
Aug 23

3 Australian Founder Led Stocks Retail Investors May Want On Their Watchlist

Simply Wall St.
·
Aug 23

3 Founder Led Growth Stocks With High Insider Ownership On The ASX

Simply Wall St.
·
Aug 22

WiseTech Global Stock And 2 Cash Flow Plays Worth A Closer Look

Simply Wall St.
·
Aug 21

Mesoblast Stock Leads 3 High Growth Insider Owned ASX Shares To Watch

Simply Wall St.
·
Aug 21

3 Australian Penny Stocks With Strong Balance Sheets On The Radar

Simply Wall St.
·
Aug 21

3 Australian Founder Led Stocks Retail Investors Are Tracking In A Higher Rate World

Simply Wall St.
·
Aug 20

ASX Stocks Including Cogstate That May Be Trading Below Estimated Value

Simply Wall St.
·
Aug 20

Fast Growing Stocks With High Insider Ownership That Analysts Expect To Scale

Simply Wall St.
·
Aug 20

Alkane Resources Stock Leads These Financially Fit Penny Stocks

Simply Wall St.
·
Aug 19

Founder Led Stocks With Long Term Skin In The Game

Simply Wall St.
·
Aug 19

ASX Stocks Estimated To Be Trading Below Fair Value In August 2026

Simply Wall St.
·
Aug 19

ASX Insights Lynas Rare Earths And 2 Stocks That Might Be Priced Below Their Estimated Value

Simply Wall St.
·
Aug 18

Why Retail Investors Are Tracking These 3 Founder Led Australian Stocks Today

Simply Wall St.
·
Aug 17

Mesoblast Completes Dosing in Phase 3 Rexlemestrocel-L Trial for Chronic Low Back Pain

Reuters
·
Aug 17

Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain

THOMSON REUTERS
·
Aug 17

ASX August 2026 Stocks That May Be Trading Below Estimated Value

Simply Wall St.
·
Aug 17